Courts Stop Harmful “Public Charge” Rule from Taking Effect

Julie CarterMedicare WatchLeave a Comment

This month, five federal courts temporarily blocked a Trump administration final rule that would greatly harm families and prevent people with Medicare from accessing the services and supports they need to thrive. The new “public charge” policy was set to become effective on October 15, 2019, but the recently-issued nationwide injunctions will prohibit the rule from taking effect—for now. The Read More...

House Committees Advance Drug Pricing Legislation

Lindsey CopelandMedicare WatchLeave a Comment

In recent weeks, several committees within the U.S. House of Representatives—Energy & Commerce, Education & Labor, and Ways & Means—have been working to finalize the House’s drug pricing bill, HR 3. While the bill advanced by each committee differs slightly, the underlying goals are unchanged from the version initially introduced. Read More...

U.S. House Moving Forward with Drug Pricing Bill

Lindsey CopelandMedicare WatchLeave a Comment

Lawmakers in the U.S. House of Representatives are continuing work on their drug pricing bill, H.R. 3, with hopes of holding a vote later this month. Unveiled in September, H.R. 3 includes a number of provisions that would improve prescription drug access and affordability for people with Medicare. Among the bill’s critical reforms are those allowing Medicare to negotiate drug prices; the imposition of inflationary rebates on certain drugs in Parts B and D; and a restructuring of the Part D benefit that would cap out-of-pocket costs, reduce the federal government’s liability, and better align pricing incentives. Read More...

Big Changes May Be in Store for Medicare Part D

Julie CarterMedicare WatchLeave a Comment

Some changes are in store for Part D in 2020 and policymakers are contemplating even more. The Kaiser Family Foundation (KFF), a nonpartisan nonprofit focused on national health issues, recently outlined what the program will look like next year under current law, and under recent legislative and administrative proposals. Read More...

Trump Administration Releases Vague Medicare Executive Order

Lindsey CopelandMedicare WatchLeave a Comment

Last week, the Trump Administration released a wide-ranging yet ambiguous Executive Order (EO) focused on the Medicare program. Many of the EO provisions lack specifics, making it difficult to predict what, if any, policies or recommendations may emerge. Since any policies that do emerge would likely require legislative or regulatory action before taking effect, the EO’s prospects for impacting the program are also unknown. Read More...